Deborah Knobelman
Equibles does not estimate personal net worth.
About Deborah Knobelman
Earlier roles on record: CFO at Senti Biosciences Holdings, Inc. (SNTI) until May 3, 2024. Senti Biosciences Holdings, Inc. reported in an 8-K filed April 26, 2024 that Deborah Knobelman resigned as Chief Financial Officer, Treasurer and Head of Corporate Development, effective May 3, 2024. The proxy statement of Senti Biosciences Holdings, Inc. reports total compensation of $789,656 for Deborah Knobelman in fiscal 2023, including a base salary of $460,013. Disclosed compensation is on record for 2 fiscal years.
“On April 23, 2024, Deborah Knobelman, Ph.D., the Chief Financial Officer, Treasurer and Head of Corporate Development of Senti Biosciences Inc. ("the Company") and its principal financial officer and principal accounting officer, notified the Company of her decision to resign from her employment with the Company, effective May 3, 2024.”
Affiliation history
-
Start not stated–2024-05-03
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Senti Biosciences Holdings, Inc. (SNTI) | Former Chief Financial Officer, Treasurer and Head of Corporate Development | $460,013 | $789,656 |
| 2022 | Senti Biosciences Holdings, Inc. (SNTI) | Former Chief Financial Officer, Treasurer and Head of Corporate Development | $424,981 | $1,103,425 |